European Child & Adolescent Psychiatry · 2015 · 28 citations · 21 references
MedicinePharmacotherapyPsychiatryChild PsychiatryPediatric Clinical PharmacologyPsychopharmacologyAttention-deficit/hyperactivity DisorderChild PsychopharmacologyNeurodevelopmental DisordersPediatric PsychopharmacologyPsychopharmacology In AdolescentsPsychopharmacology In ChildrenAdhd Functional ImpairmentAdhd PharmacotherapyAdhd TreatmentAdolescent AdhdChildhood AdhdDouble-blind TrialsInadequate TreatmentPediatric Stimulant Medications
Attention-deficit/hyperactivity disorder (ADHD) is associated with functional impairments in multiple domains of patients' lives. A secondary objective of this randomized, active-controlled, head-to-head, double-blind, dose-optimized clinical trial was to compare the effects of lisdexamfetamine dimesylate (LDX) and atomoxetine (ATX) on functional impairment in children and adolescents with ADHD. Patients aged 6-17 years with an ADHD Rating Scale IV total score ≥ 28 and an inadequate response to methylphenidate treatment (judged by investigators) were randomized (1:1) to once-daily LDX or ATX for 9 weeks. Parents/guardians completed the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P) at baseline and at week 9 or early termination. p values were nominal and not corrected for multiple comparisons. Of 267 randomized patients, 200 completed the study (LDX 99, ATX 101). At baseline, mean WFIRS-P total score in the LDX group was 0.95 [standard deviation (SD) 0.474; 95% confidence interval (CI) 0.87, 1.03] and in the ATX group was 0.91 (0.513; 0.82, 1.00). Scores in all WFIRS-P domains improved from baseline to endpoint in both groups, with least-squares mean changes in total score of -0.35 (95% CI -0.42, -0.29) for LDX and -0.27 (-0.33, -0.20) for ATX. The difference between LDX and ATX was statistically significant (p < 0.05) for the Learning and School (effect size of LDX vs ATX, 0.43) and Social Activities (0.34) domains and for total score (0.27). Both treatments reduced functional impairment in children and adolescents with ADHD; LDX was statistically significantly more effective than ATX in two of six domains and in total score.
21
Jacob Cohen · Psychological Bulletin · 1992 · 42.2K citations
Jacob Cohen · Psychological Bulletin · 1992 · 8.8K citations
Kathleen W. Wyrwich, William M. Tierney, Fredric D. Wolinsky · Journal of Clinical Epidemiology · 1999 · 868 citations